Exelixis, Inc.
EXEL
$40.81
$0.010.03%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/7/2025
-
MarketBeat
11/7/2025
-
TipRanks Financial Blog
11/7/2025
-
The Fly
11/7/2025
-
Simply Wall St
11/7/2025
-
SeekingAlpha
11/6/2025
-
GuruFocus
11/6/2025
-
Business Wire
11/6/2025
-
MarketBeat
11/6/2025
-
MarketBeat
11/6/2025
-
MarketBeat
11/6/2025
-
GuruFocus
11/6/2025
-
MarketBeat
11/6/2025
-
The Fly
11/6/2025
-
Zacks Investment Research
11/6/2025
-
Simply Wall St
11/6/2025
-
Tickeron - Stocks
11/5/2025
-
Ticker Report
11/5/2025
-
GuruFocus
11/5/2025
-
TipRanks Financial Blog
11/5/2025
-
The Fly
11/5/2025
-
Zacks Investment Research
11/5/2025
-
SeekingAlpha
11/5/2025
-
The Fly
11/5/2025
-
The Fly
11/5/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 837 7000
Address
1851 Harbor Bay Parkway
Alameda, CA 94502
Alameda, CA 94502
Country
Year Founded
Business Description
Sector
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers...
more